Systemic levels of vascular endothelial growth factor before and after intravitreal injection of aflibercept or ranibizumab in patients with age-related macular degeneration: a randomised, prospective trial.

Abstract

PURPOSE To evaluate the changes of vascular endothelial growth factor (VEGF) plasma levels after intravitreal injections of aflibercept or ranibizumab in patients with exudative age-related macular degeneration (AMD). METHODS Thirty-eight patients with exudative AMD were included in this randomised, prospective study. Nineteen patients were randomised to… (More)
DOI: 10.1111/aos.12604

Topics

  • Presentations referencing similar topics